Venture capitalists return to biotechnology, life sciences

09/25/2012 | Reuters

Venture-backed investments in biotechnology rose by 24% to $4.82 billion last year over 2010 figures, and venture firms are raising more funds this year dedicated to life sciences, biotech and medicine. Established drugmakers seeking refilled pipelines are increasingly investing in early-stage research, and some have set up their own venture funds. Regulations and policies that speed drug approvals could also accelerate returns and attract more funds, investors say.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT